Peri-implant mucositis and peri-implantitis are examined as possible diseases. This can be seen analogously to ICD 10 K05.1 and K05.2. K05.1 K05.2
Conditions
Interventions
Group 1: The treatment of each patient is based on an individual treatment plan and only if it appears justified, two short implants (Zimmer Biomet T3® Short Implants with a diameter of 5 mm and lengt
Sponsors
Danube Private University GmbH (DPU)
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: - Sane adults, i.e., patients capable of giving consent - Good general health (ASA = 2 [32]) a. Diabetes mellitus should be well controlled (HbA1c <7) b. Smoking = 20 cigarettes / day c. No alcohol or drug abuse - No pathology of bone metabolism - Patients with periodontitis should be treated successfully, i.e., no residual periodontal infection - Good oral hygiene and compliance, i.e., plaque level (full-mouth plaque score, FMPS) <25% and bleeding level after probing (full-mouth bleeding on probing score, FMBS) <25% - A 3D radiographic bone width = 8 mm and a bone height of 5 - 6 mm in the posterior maxilla or 7 - 8 mm in the posterior mandible A bone height in the posterior maxilla of less than 5 mm is permissible if the existing bone height - in conjunction with an internal sinus lift performed at the same time - allows sufficient primary implant stability. - Tooth extraction must have taken place at least three months ago - Existing opposing teeth - Patients must be willing to adhere to a prevention concept (supportive therapy, UT). This is a routine protocol. - Written declaration of consent to participate in this study
Exclusion criteria
Exclusion criteria: - Minors - Pregnant and breastfeeding patients - Taking anti-resorptive drugs - Patients with a known allergy to titanium - Patients with proven bruxism
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Primary study parameter The primary study parameter is peri-implant marginal bone level change (?PMK implant) at two short (length = 6 mm), functionally loaded (splinted crowns) implants. Determination of the primary study parameter Measurement of digital x-rays immediately after implantation, prosthetic loading and yearly after loading. | — |
Secondary
| Measure | Time frame |
|---|---|
| most important secondary study The most important secondary study parameter is the determination of the cumulative implant loss rate (KVimplant). Determination of the most important secondary study parameter The cumulative implant loss rate at implant level (KVImplant) is calculated as the number of non-surviving implants divided by the number of all implants (intention-to-treat investigation) multiplied by 100 percent. | — |
Countries
Austria
Contacts
Public ContactRüdiger Junker
Danube Private University GmbH (DPU)
Outcome results
None listed